NASDAQ:KTRA
Delisted

Kintara Therapeutics Stock Predictions

etoro logo Buy KTRA
*Your capital is at risk
$0.215
+0 (+0%)
At Close: Jan 16, 2025
Currently predicting for Fri, 5 Jun 2026

KTRA Prediction Chart

KTRA Predictions History

Latest community submissions for KTRA.
Predictor Target Session Target Price Result Direction Accuracy Score
AlexVel AlexVel Pro
Dec 27, 2023 $0.176 +1.68% $0.180 V 97.78% 1
Dec 27, 2023 $0.192 +10.87% $0.180 V 93.38% 1
Dec 27, 2023 $0.203 +17.39% $0.180 V 87.11% 1
Dec 26, 2023 $0.208 +18.09% $0.173 X 79.86% 0
Dec 26, 2023 $0.196 +11.31% $0.173 X 86.76% 0
JS JS Pro
Dec 20, 2023 $0.183 -0.33% $0.182 V 99.17% 3
Dec 20, 2023 $0.221 +20.27% $0.182 X 78.34% 0
Dec 20, 2023 $0.207 +12.67% $0.182 X 86.03% 0
JS JS Pro
Dec 14, 2023 $0.190 +1.06% $0.200 V 95.00% 1
Dec 14, 2023 $0.235 +24.93% $0.200 V 82.57% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for KTRA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT KINTARA THERAPEUTICS INC.
Kintara Therapeutics
Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intri...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE